VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, COVID-19 and coronaviruses, and cytomegalovirus (“CMV”), as well as aggressive cancers including glioblastoma (“GBM”). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel.
VBI Vaccines
Unlock to Claim this listing
Add / Modify Company
0.07
Overall Excellence Rating
Industry
Gas & Mining, OilCategory
Biotechnology ResearchESG/Ethical Impact
Within the realm of environmental stewardship, VBI Vaccines demonstrates an unwavering dedication to minimizing its ecological footprint and advancing sustainability. By integrating innovative practices such as eco-friendly manufacturing processes, responsible resource management, and sustainable packaging solutions, the company actively contributes to environmental conservation, aligning its operations with the imperative of safeguarding the planet’s resources for current and future generations. Social impact stands as a foundational pillar of VBI Vaccines’ ethos, as it places a premium on enhancing the well-being of individuals, patients, and the communities it serves. Through its cutting-edge vaccine solutions, the company empowers individuals to access improved health outcomes. Financial prudence and resilience are integral to VBI Vaccines’ sustained success, as evidenced by its strategic financial management practices that fortify the company’s enduring viability. By cultivating a strong financial foundation, VBI Vaccines ensures its ability to navigate economic fluctuations, enabling the consistent delivery of innovative vaccine solutions and contributing to improved public health outcomes and global well-being. Ethics permeate every facet of VBI Vaccines’ operations, reflecting its unwavering commitment to conducting business with the utmost integrity. This commitment is palpable in the company’s clinical trial practices, responsible research, and unwavering adherence to regulatory mandates, solidifying VBI Vaccines’ status as a guardian of ethical business conduct and patient safety within the healthcare landscape.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
8120000.00
Website Traffic
Employee Rating
2.80
Customer Rating
Company Size
100-1000
ESG Risk Rating
3.00